Replies to post #400764 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

OK, so no bubbles no troubles then. But expected since when?
On September 23 there was still hope expressed here: "And the Alfasigma Brilacidin license is worth USD$24 million after milestones. Plus royalty."
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172909484&txt2find=alfasigma

Is this what you mean by expected?
" The Company recently learned that Alfasigma is considering terminating further work under the License Agreement, although as of the date of this report, Alfasigma has not notified the Company of the termination of the License Agreement or a cessation of further work under the License Agreement."
That's from the CEO himself 2 weeks ago.